What are the recommended N‑acetylcysteine dosing regimens and the minimum age for its use in children for acetaminophen overdose and for mucolytic therapy?

N-Acetylcysteine Dosing and Minimum Age

For acetaminophen overdose, N-acetylcysteine (NAC) should be administered to children of all ages using weight-based dosing (loading dose 140 mg/kg, then 70 mg/kg every 4 hours for 17 doses orally, or newer two-bag IV regimen: 200 mg/kg over 4 hours, then 100 mg/kg over 16 hours), with no minimum age restriction specified in FDA labeling, though guideline evidence only formally addresses patients older than 12 years. 1

Acetaminophen Overdose Dosing

Standard Oral Regimen (FDA-Approved)

The FDA-labeled oral dosing is weight-based without age restrictions 1:

• Loading dose: 140 mg/kg body weight
• Maintenance doses: 70 mg/kg every 4 hours for 17 additional doses (total 72 hours)
• Dilute 20% solution to 5% concentration using diet cola or soft drinks (or water if via gastric tube)
• For patients <20 kg (typically <6 years): calculate exact doses using 200 mg/mL concentration 1

Intravenous Regimens

Two-bag regimen (preferred based on recent evidence):

• 200 mg/kg over 4 hours, then 100 mg/kg over 16 hours 2, 3, 4
• Significantly fewer medication errors (23% vs 39%, p=0.01) 3
• Fewer cutaneous anaphylactoid reactions (2% vs 10%, p=0.02) 3
• Use 0.45% saline with 5% dextrose in children to prevent hyponatraemia 5

Traditional three-bag regimen:

• 150 mg/kg over 1 hour, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours
• Higher rates of administration errors and adverse reactions 3, 4

Age Considerations

Critical Limitation in Guidelines

The 2007 ACEP guidelines explicitly exclude patients ≤12 years from their recommendations, stating the Rumack-Matthew nomogram was developed using data from patients >12 years 6. However, this represents a guideline limitation, not a contraindication to NAC use in younger children.

Practical Application Across All Ages

• FDA labeling provides weight-based dosing for all ages without minimum age restriction 1
• Recent pediatric studies include children as young as 3 months 5
• Mean age in pediatric NAC studies: 8.5-9.5 years, with ranges from 3 months to 17 years 5, 7
• NAC is well-tolerated in children with uncommon side effects 7

Treatment Timing

Administer NAC immediately if ≤24 hours from ingestion, regardless of acetaminophen level results 1:

• Optimal window: Within 8 hours (2.9% hepatotoxicity rate) 6
• Acceptable window: 8-10 hours (6.1% hepatotoxicity rate) 6
• Late presentation: 10-24 hours (26.4% hepatotoxicity rate, but still beneficial) 6
• Even treatment at 12-24 hours shows significant mortality reduction 6

Risk Stratification Using Rumack-Matthew Nomogram

For patients >12 years with acute single ingestion at known time 6:

• Draw acetaminophen level at 4-24 hours post-ingestion
• Treat if level plots above "possible risk" line (25% below original nomogram line) 6
• Do not treat if clearly below nomogram line (Level B recommendation) 6
• Initiate treatment before level results if presentation is within treatment window 1

Special Circumstances Requiring Treatment Regardless of Nomogram

Treat with NAC in these scenarios 6:

• Hepatic failure or hepatotoxicity thought due to acetaminophen
• Unknown or unreliable ingestion time with detectable acetaminophen level
• Repeated supratherapeutic ingestions
• Modified/extended-release formulations (≥10 g or ≥200 mg/kg) 2
• Massive overdoses (≥30 g or ≥500 mg/kg require increased NAC doses) 2

Mucolytic Therapy

For cystic fibrosis patients ≥6 years, the evidence is insufficient to recommend for or against chronic inhaled or oral NAC as a mucolytic (Grade I recommendation) 8. This represents a different indication with inadequate evidence, not a safety concern.

Key Clinical Pitfalls

1. Don't wait for acetaminophen levels if patient presents early—start NAC immediately 1
2. Don't withhold NAC in young children due to guideline age restrictions—FDA dosing is weight-based for all ages 1
3. Repeat vomited doses within 1 hour of oral administration 1
4. Consider duodenal intubation if persistent vomiting with oral route 1
5. Use saline-containing solutions (0.45% NaCl + 5% dextrose) for IV NAC in children to prevent hyponatraemia 5
6. Activated charcoal adsorbs NAC—if given, perform gastric lavage before NAC administration 1